GI
XLRN

GAMCO Investors’s Acceleron Pharma XLRN Stock Holding History

GAMCO Investors’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,378
Closed -$926K – 963
2021
Q3 		$926K Buy
+5,378
New +$703K 0.01% 640

GAMCO Investors's XLRN Position: Q4 2021 in Review

GAMCO Investors sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 5,378 shares — an estimated $926K sold.

GAMCO Investors first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $926K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • GAMCO Investors reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • GAMCO Investors sold 5,378 Acceleron Pharma shares in Q4 2021, an estimated $926K.
  • GAMCO Investors first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
  • GAMCO Investors's Acceleron Pharma position peaked at $926K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on GAMCO Investors's 13F filing for Q4 2021, filed 11 Feb 2022.